Interest of extracellular vesicles in regards to lipid nanoparticle based systems for intracellular protein delivery

39Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Compared to chemicals that continue to dominate the overall pharmaceutical market, protein therapeutics offer the advantages of higher specificity, greater activity, and reduced toxicity. While nearly all existing therapeutic proteins were developed against soluble or extracellular targets, the ability for proteins to enter cells and target intracellular compartments can significantly broaden their utility for a myriad of exiting targets. Given their physical, chemical, biological instability that could induce adverse effects, and their limited ability to cross cell membranes, delivery systems are required to fully reveal their biological potential. In this context, as natural protein nanocarriers, extracellular vesicles (EVs) hold great promise. Nevertheless, if not present naturally, bringing an interest protein into EV is not an easy task. In this review, we will explore methods used to load extrinsic protein into EVs and compare these natural vectors to their close synthetic counterparts, liposomes/lipid nanoparticles, to induce intracellular protein delivery.

Cite

CITATION STYLE

APA

Le Saux, S., Aubert-Pouëssel, A., Mohamed, K. E., Martineau, P., Guglielmi, L., Devoisselle, J. M., … Morille, M. (2021, September 1). Interest of extracellular vesicles in regards to lipid nanoparticle based systems for intracellular protein delivery. Advanced Drug Delivery Reviews. Elsevier B.V. https://doi.org/10.1016/j.addr.2021.113837

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free